{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRGS9 is a member of the regulator of G protein signaling family that plays critical roles in both visual and neuronal systems. In the retina, the RGS9‐1 splice isoform is anchored by R9AP to photoreceptor membranes and functions as a GTPase‐accelerating protein (GAP) to rapidly deactivate transducin, enabling timely recovery from the light response. Mutations in RGS9 or R9AP lead to a marked delay in deactivation, manifesting clinically as bradyopsia—characterized by difficulty adapting to sudden changes in luminance and impaired tracking of moving or low‐contrast objects. Notably, while patients with cone dysfunction show such adaptation deficits, similar studies screening for mutations in retinitis pigmentosa patients have not implicated RGS9, underscoring its selective role in rapid phototransduction recovery."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the central nervous system, a distinct splice variant—RGS9‐2—is enriched in the striatum where it modulates dopamine and opioid receptor signaling. RGS9‐2 forms trimeric complexes with the atypical G protein Gβ5 and membrane anchors such as R7BP, which collectively enhance its GAP activity. This assembly confers selectivity for Gα subunits, preferentially attenuating Go over Gi signals and even directly influencing receptor down‐regulation, as seen with the dopamine D2 receptor. Such discrete regulation of receptor internalization and signal termination is crucial for controlling motor function, reward processing, and possibly susceptibility to movement and psychiatric disorders."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe functional effectiveness of RGS9 is intimately linked to its ability to form a stable complex with partner proteins. Biochemical studies have demonstrated that the association with Gβ5 is necessary for facilitating the binding of membrane anchors and, thereby, ensuring proper subcellular localization and proteolytic stability. Investigations using yeast complementation models have further underscored that the GGL domain of RGS9 is critical for its interaction with Gβ5, suggesting that under certain cellular conditions the RGS9/Gβ5 complex may even mimic traditional Gβγ functions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nGenetic variations in the RGS9 gene have been implicated in a variety of clinical conditions linked to aberrant GPCR signaling. For instance, altered RGS9 activity has been associated with tardive dyskinesia in patients chronically treated with antipsychotics, while polymorphisms have also been correlated with susceptibility to heroin dependence and schizophrenia. In addition, experimental modulation of RGS9‐2 levels in the nucleus accumbens influences body weight, with overexpression reducing and knockout leading to increased adiposity. These findings, together with broader studies on genetic variations in RGS family members, highlight the significance of RGS9 in maintaining precise GPCR signaling thresholds in both neurological and metabolic contexts."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "15"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Koji M Nishiguchi, Michael A Sandberg, Aart C Kooijman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature02170"}], "href": "https://doi.org/10.1038/nature02170"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14702087"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14702087"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Michel Michaelides, Zheng Li, Naheed A Rana, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel mutations and electrophysiologic findings in RGS9- and R9AP-associated retinal dysfunction (Bradyopsia)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ophthalmology (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ophtha.2009.06.011"}], "href": "https://doi.org/10.1016/j.ophtha.2009.06.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19818506"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19818506"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Arif O Khan "}, {"type": "b", "children": [{"type": "t", "text": "The clinical presentation of bradyopsia in children."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J AAPOS (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jaapos.2017.07.212"}], "href": "https://doi.org/10.1016/j.jaapos.2017.07.212"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29107794"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29107794"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Qing-jiong Zhang, Wei Li, Xue-shan Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Analysis of GUCA1B,GNGT1 and RGS9 genes in patients with retinitis pigmentosa]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Yi Chuan (2002)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15901556"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15901556"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Kirill A Martemyanov, Vadim Y Arshavsky "}, {"type": "b", "children": [{"type": "t", "text": "Biology and functions of the RGS9 isoforms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prog Mol Biol Transl Sci (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S1877-1173(09)86007-9"}], "href": "https://doi.org/10.1016/S1877-1173(09"}, {"type": "t", "text": "86007-9) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20374717"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20374717"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Jeremy Celver, Meenakshi Sharma, Abraham Kovoor "}, {"type": "b", "children": [{"type": "t", "text": "RGS9-2 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurochem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1471-4159.2010.06805.x"}], "href": "https://doi.org/10.1111/j.1471-4159.2010.06805.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20477943"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20477943"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Ikuo Masuho, Keqiang Xie, Kirill A Martemyanov "}, {"type": "b", "children": [{"type": "t", "text": "Macromolecular composition dictates receptor and G protein selectivity of regulator of G protein signaling (RGS) 7 and 9-2 protein complexes in living cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M113.462283"}], "href": "https://doi.org/10.1074/jbc.M113.462283"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23857581"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23857581"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Mei Zheng, Sang-Yoon Cheong, Chengchun Min, et al. "}, {"type": "b", "children": [{"type": "t", "text": "β-arrestin2 plays permissive roles in the inhibitory activities of RGS9-2 on G protein-coupled receptors by maintaining RGS9-2 in the open conformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.05690-11"}], "href": "https://doi.org/10.1128/MCB.05690-11"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22006018"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22006018"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Ikuo Masuho, Hideko Wakasugi-Masuho, Ekaterina N Posokhova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Type 5 G protein beta subunit (Gbeta5) controls the interaction of regulator of G protein signaling 9 (RGS9) with membrane anchors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.241513"}], "href": "https://doi.org/10.1074/jbc.M111.241513"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21511947"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21511947"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Seena K Ajit, Kathleen H Young "}, {"type": "b", "children": [{"type": "t", "text": "Enhancement of pheromone response by RGS9 and Gbeta5 in yeast."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2004.09.100"}], "href": "https://doi.org/10.1016/j.bbrc.2004.09.100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15474482"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15474482"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Ying-Jay Liou, Mao-Liang Chen, Ying-Chieh Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet B Neuropsychiatr Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.b.30796"}], "href": "https://doi.org/10.1002/ajmg.b.30796"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18548510"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18548510"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jeffrey L Waugh, Jeremy Celver, Meenakshi Sharma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between regulator of G protein signaling 9-2 and body weight."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0027984"}], "href": "https://doi.org/10.1371/journal.pone.0027984"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22132185"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22132185"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Yongsheng Zhu, Hongbo Zhang "}, {"type": "b", "children": [{"type": "t", "text": "Evidence for the contribution of genetic variations in regulator of G protein signaling 9 to the genetic susceptibility of heroin dependence."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2015.3210"}], "href": "https://doi.org/10.3892/mmr.2015.3210"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25591550"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25591550"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Y S Zhu, Y X Li, X M Qiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulators of G-protein signaling 9 genetic variations in Chinese subjects with schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genet Mol Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4238/2015.July.28.13"}], "href": "https://doi.org/10.4238/2015.July.28.13"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26345773"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26345773"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Jianming Wang, Scott M Lippman, J Jack Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgq138"}], "href": "https://doi.org/10.1093/carcin/bgq138"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20627871"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20627871"}]}]}]}